联环药业(600513)6月30日股东户数3.01万户，较上期减少0.72%

Core Viewpoint - Lianhuan Pharmaceutical reported a decrease in shareholder accounts and average shareholding value, indicating a trend of reduced investor engagement despite a slight increase in stock price over the observed period [1][2]. Group 1: Shareholder Statistics - As of June 30, 2025, the number of shareholders for Lianhuan Pharmaceutical was 30,095, a decrease of 218 accounts or 0.72% from March 31, 2025 [1][2]. - The average number of shares held per account increased from 9,417 shares to 9,485 shares, with an average market value of 95,100 yuan [1][2]. - Compared to the chemical pharmaceutical industry, Lianhuan's shareholder count is below the industry average of 33,000 accounts, and its average market value is significantly lower than the industry average of 394,700 yuan [1][2]. Group 2: Stock Performance - From March 31, 2025, to June 30, 2025, Lianhuan Pharmaceutical's stock price increased by 2.51%, while the number of shareholders decreased [1][2]. - During this period, the net outflow of funds from major investors was 74.91 million yuan, while retail investors contributed a net inflow of 88.67 million yuan [2].